![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 24, 16576-16582, June 16, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



1
From the
Department of Biochemistry, University of Cambridge, and the
Neurobiology Division, Laboratory of Molecular Biology, Cambridge, United Kingdom
The 5-HT3 receptor is a member of the Cys-loop family of ligandgated ion channels. The extracellular domains of these proteins contain six amino acid loops (AF) that converge to form the ligand binding site. In this study we have mutated 21 residues in or close to the 5-HT3 receptor F-loop (Ile192 to Gly212) to Ala or to a residue with similar chemical properties. Mutant receptors were expressed in HEK293 cells, and binding affinity was measured using [3H]granisetron. Two regions displayed decreases in binding affinity when mutated to Ala (Ile192Arg196 and Asp204Ser206), but only one region was sensitive when mutated to chemically similar residues (Ile192Val201). Homology modeling using acetylcholine-binding protein crystal structures with a variety of different bound ligands suggests there may be distinct movements of Trp195 and Asp204 upon ligand binding, indicating that these residues and their immediate neighbors have the ability to interact differently with different ligands. The models suggest predominantly lateral movement around Asp204 and rotational movement around Trp195, indicating the former is in a more flexible region. Overall our results are consistent with a flexible 5-HT3 receptor F-loop with two regions that have specific but distinct roles in ligand binding.
Received for publication, February 9, 2006 , and in revised form, March 29, 2006.
* This work was supported by the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, and Merck Sharp and Dohme. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 A Wellcome Trust Senior Research Fellow in Basic Biomedical Studies. To whom correspondence should be addressed: Dept. of Biochemistry, University of Cambridge, Cambridge CB2 1QW, United Kingdom. Tel.: 44-1223-765-950; Fax: 44-1223-333-345; E-mail: sl120{at}cam.ac.uk.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. M. Hanson and C. Czajkowski Structural Mechanisms Underlying Benzodiazepine Modulation of the GABAA Receptor J. Neurosci., March 26, 2008; 28(13): 3490 - 3499. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Padgett and S. C. R. Lummis The F-loop of the GABAA Receptor {gamma}2 Subunit Contributes to Benzodiazepine Modulation J. Biol. Chem., February 1, 2008; 283(5): 2702 - 2708. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Sancar, S. S. Ericksen, A. M. Kucken, J. A. Teissere, and C. Czajkowski Structural Determinants for High-Affinity Zolpidem Binding to GABA-A receptors Mol. Pharmacol., January 1, 2007; 71(1): 38 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Hibbs, Z. Radic, P. Taylor, and D. A. Johnson Influence of Agonists and Antagonists on the Segmental Motion of Residues near the Agonist Binding Pocket of the Acetylcholine-binding Protein J. Biol. Chem., December 22, 2006; 281(51): 39708 - 39718. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |